Literature DB >> 7540023

The influence of nitric oxide on tumour vascular tone.

G M Tozer1, V E Prise, K M Bell.   

Abstract

Acetylcholine and sodium nitroprusside, which vasodilate via release of NO by endothelium-dependent and endothelium-independent mechanisms respectively, had little effect on tumour vascular resistance when administered to tissue-isolated tumours perfused in their normal state. However, under phenylephrine-induced vasoconstriction, sodium nitroprusside induced vasodilation whilst acetylcholine induced a small vasoconstriction. Phenylephrine itself induced an oscillatory change in tumour perfusion pressure. The nitric oxide synthase (NOS) inhibitor N omega-nitro-L-arginine (L-NNA) caused a dose-dependent increase in vascular resistance in ex vivo perfused tumours which was greater than that in normal perfused hindlimbs. Systemic administration of L-NNA caused a 50% decrease in tumour blood flow which was a larger effect than in any of the normal tissues studied except spleen and skeletal muscle. Modification of NOS activity in tumours is a promising means for selective tumour blood flow modification. Investigation of endothelium-dependent versus endothelium-independent methods for modifying tumour blood flow may provide methods for further selectivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540023     DOI: 10.3109/02841869509093992

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions.

Authors:  D Fukumura; F Yuan; M Endo; R K Jain
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.

Authors:  M R Horsman; D J Chaplin; S A Hill; S Arnold; D Collingridge; M Radacic; P J Wood; J Overgaard
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents.

Authors:  M Kurimoto; S Endo; Y Hirashima; H Hamada; T Ogiichi; A Takaku
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

4.  Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow.

Authors:  I R Whittle; F Collins; P A Kelly; I Ritchie; J W Ironside
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.

Authors:  G M Tozer; V E Prise; K M Bell; M F Dennis; M R Stratford; D J Chaplin
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth.

Authors:  K Doi; T Akaike; S Fujii; S Tanaka; N Ikebe; T Beppu; S Shibahara; M Ogawa; H Maeda
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

7.  Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.

Authors:  S A Butler; P J Wood; S Cole; C Williams; G E Adams; I J Stratford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.